Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis
…, ME Husni, TJ Love, E Lubrano… - Arthritis & …, 2016 - Wiley Online Library
Objective To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic
Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting …
Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting …
[HTML][HTML] Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
…, J Latella, YY Leung, C Lindsay, E Lubrano… - Nature Reviews …, 2022 - nature.com
Since the second version of the Group for Research and Assessment of Psoriasis and
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …
Psoriatic Arthritis (GRAPPA) treatment recommendations were published in 2015, therapeutic …
Consensus on a core set of domains for psoriatic arthritis.
…, D Van Der Heijde, E Husni, E Lubrano… - The Journal of …, 2007 - jrheum.org
A psoriatic arthritis (PsA) module was convened at OMERACT 8 in order to achieve
consensus on the core domains that should be included in randomized controlled trials and …
consensus on the core domains that should be included in randomized controlled trials and …
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)
…, P Healy, EM Kerzberg, YJ Lee, E Lubrano… - Annals of the …, 2013 - ard.bmj.com
Objective To develop new composite disease activity indices for psoriatic arthritis (PsA).
Methods Data from routine clinic visits at multiple centres were collected in a systematic manner. …
Methods Data from routine clinic visits at multiple centres were collected in a systematic manner. …
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid …
…, RD Grembiale, V Liakouli, R Lories, E Lubrano… - Autoimmunity …, 2017 - Elsevier
Autoimmune diseases are a complex set of diseases characterized by immune system
activation and, although many progresses have been done in the last 15 years, several unmet …
activation and, although many progresses have been done in the last 15 years, several unmet …
Drug-induced lupus erythematosus.
P Sarzi-Puttini, F Atzeni, F Capsoni, E Lubrano… - …, 2005 - search.ebscohost.com
Drug-induced lupus is a syndrome which share symptoms and laboratory characteristics
with idiopathic systemic lupus erythematosus (SLE). The terms drug-induced lupus (DIL) and …
with idiopathic systemic lupus erythematosus (SLE). The terms drug-induced lupus (DIL) and …
Patient global assessment in psoriatic arthritis: a multicenter GRAPPA and OMERACT study
…, C Salvarani, JR Kalden, E Lubrano… - The Journal of …, 2011 - jrheum.org
Objective. During OMERACT 8, delegates selected patient global assessment (PGA) of
disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). …
disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). …
Outcome measures in psoriatic arthritis.
…, PS Helliwell, O Fitzgerald, A Cauli, E Lubrano… - The Journal of …, 2007 - jrheum.org
Psoriatic arthritis (PsA), an inflammatory arthritis associated with psoriasis usually
seronegative for rheumatoid factor, has emerged as a more common and severe disease than …
seronegative for rheumatoid factor, has emerged as a more common and severe disease than …
Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia
A Marchesoni, F Atzeni, A Spadaro, E Lubrano… - The Journal of …, 2012 - jrheum.org
Objective. To identify the clinical features that can help to distinguish between psoriatic
arthritis (PsA) and fibromyalgia (FM). Methods. Our cross-sectional study was carried out in 10 …
arthritis (PsA) and fibromyalgia (FM). Methods. Our cross-sectional study was carried out in 10 …
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries
Background The objective was to compare different definitions of remission and low disease
activity (LDA) in patients with psoriatic arthritis (PsA), based on both patients’ and physicians…
activity (LDA) in patients with psoriatic arthritis (PsA), based on both patients’ and physicians…